Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer

NCT02682589 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1080

Last updated 2016-07-06

No results posted yet for this study

Summary

Randomized, multicenter, phase III trial to compare the short and long outcomes of laparoscopic CME with open CME in treating patients with locally advanced colon cancer.

Conditions

Interventions

PROCEDURE

Open surgery

A traditional midline incision is made through the abdominal wall and a colectomy with CME is performed.

PROCEDURE

Laparoscopic surgery

3-5 small incisions are made through the abdominal wall for the placement of trocars and the abdominal cavity is insufflated with carbon dioxide to allow access, visualization and operation. A 6-8cm auxiliary incision is made for specimen extraction and anastomosis. Conversion may occur due to technical difficulties or intraoperative complications, which is defined when completion of the dissection of the mesocolon is performed through a traditional open abdominal approach. Patients undergo conversion to laparotomy will be excluded from this study.

Sponsors & Collaborators

  • West China Hospital

    collaborator OTHER
  • Changhai Hospital

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • Peking Union Medical College Hospital

    collaborator OTHER
  • Ruijin Hospital

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Shanghai Changzheng Hospital

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Fujian Medical University

    collaborator OTHER
  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Fumin Zhang, Professor · Ethics Committee of the First Affiliated Hospital, Nanjing Medical University, Jiangsu Province Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02682589 on ClinicalTrials.gov